Project 1: Self-Triage by 2D Full-field Digital Mammography or Synthetic Images
1 other identifier
interventional
16
1 country
1
Brief Summary
One method of breast cancer screening involves radiologists reading digital tomosynthesis (DBT) images. DBT consists of a 3D stack of x-ray "slices" through the breast. The exam is accompanied by a 2D image like a standard mammogram, a single x-ray of the breast. In a screening setting, most cases are normal. Sometimes it is obvious that a case is normal from a quick look at the 2D image. It would speed up the process of screening if readers could dismiss a clearly normal case on the basis of the 2D image, alone, without looking at the DBT images. Obviously, the investigators would only want to "triage" cases in this way if the investigators were almost perfectly sure that no cancers would be missed. In this study, the investigators look at radiologist's willingness to triage cases and on the accuracy of their answers. In addition, the investigators ask about the impact of an Artificial Intelligence (AI) opinion. Would it be possible to triage an image on the basis of the AI opinion, alone? Radiologists will look at each case for up to five seconds and offer an opinion (on a 1-10 scale) about how sure they are that a case is normal. Next, they will see the opinion of the AI. Finally, they will say (using a 1-10) scale, how willing they would be for the AI to triage this case without human intervention. This study is the start of an effort to understand the conditions under which radiologists might be willing to declare a case "normal" with little or no human examination.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 4, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 4, 2023
CompletedFirst Submitted
Initial submission to the registry
July 14, 2023
CompletedFirst Posted
Study publicly available on registry
July 25, 2023
CompletedDecember 11, 2025
December 1, 2025
3 days
July 14, 2023
December 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Abnormality rating accuracy
Readers rate the abnormality of each image. The outcome measure is the agreement with gold standard truth for that case.
through study completion, an average of 1 year
AI Acceptance rating
Readers state if they would accept the AI rating as definitive. The relevant measure is the acceptance rate as a function of AI rating and the human rating of abnormality.
through study completion, an average of 1 year
Interventions
For each case, we give the radiologist a numeric score reflecting the AI's rating of the abnormality of the case.
Eligibility Criteria
You may qualify if:
- Must be Radiologists or radiology trainees
- some experience reading mammography.
You may not qualify if:
- acuity less than 20/25 with correction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Visual Attention Lab / Brigham and Women's Hospital
Boston, Massachusetts, 02215, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- At the end of the study, the participant is debriefed about their performance.
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 14, 2023
First Posted
July 25, 2023
Study Start
March 1, 2023
Primary Completion
March 4, 2023
Study Completion
March 4, 2023
Last Updated
December 11, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- We will post data on the OSF site at the end of the study and it will remain there indefinitely
- Access Criteria
- open, and we will also respond to requests.
We share deidentified on request and, typically, on the Open Science Framework